unite de recherche - Faculté de Médecine

Transcription

POLE HOSPITALIER
BIOLOGIE
CHEF DE PÔLE : Professeur Bruno LACARELLE
ADRESSE : Hôpital de la Timone - Service de Pharmacocinétique et Toxicologie
264 Rue Saint-Pierre 13385 MARSEILLE Cedex 5
TELEPHONE : 04.91.38.75.65
COURRIEL : [email protected]
RATTACHEMENTS : AP-HM
DISCIPLINES D’APPARTENANCES : Biochimie et Biologie Moléculaire, Hématologie, Immunologie,
génétique, Biologie Cellulaire, Pharmacologie, Toxicologie, Oncologie
SPECIALITÉS : Biochimie et Biologie Moléculaire, Hématologie, Immunologie, Génétique, Biologie
Cellulaire, Pharmacologie, Toxicologie, Oncologie
EFFECTIFS
Enseignants-Chercheurs (PU-PH, MCU-PH, CCA, AHU) : 32,79 ETP
Personnel Hospitalier (PH, Attaché) : 49,04 ETP (PC, Assistant) 2,80 ETP
Personnel Technique (Encadrement) : 14,00 ETP (Techniciens de Laboratoire) : 249,50 ETP
(Ingénieurs) : 31,90 ETP (Aide de Laboratoire – AEQ & Divers) : 36,80 ETP
Personnel Administratif : 44,70 ETP
Internes : 48,60 ETP
Etudiants : 75,00 ETP
PERSONNELS RATTACHÉS A UNE EQUIPE DE RECHERCHE
INSERM UMR 911 CRO2 EQUIPE 4
L Ouafik (PU-PH)
INSERM UMR 911 CRO2
B Lacarelle (PU-PH)
C Solas (MCU-PH)
Suzanne Monjanel (MCU-Attaché)
J Ciccolini (MCU-Attaché)
UMR NORT inserm 1062, inra 1260
Marie-Christine Alessi (PU-PH) PierreEmmanuel Morange (PU-PH) Michel
Fontes (PU-PH)
Henri Portugal (PU-PH)
Marie-Françoise Aillaud (MCU-PH)
Véronique Baccini (MCU-PH)
Alain Margotat (MCU-PH)
Richard Planells (MCU-PH)
Mise à jour : janvier 2015
Pôle hospitalier. Biologie
1/21
Alain Nicolay (MCU-PH)
Marguerite Gastaldi (MCU-PH)
Catherine Defoort (MCU-PH)
Alain Nicolay (MCU-PH)
M Gastaldi (MCU-PH)
A Margotat (MCU-PH)
Charlotte Grosdidier (AHU)
Agathe Henneuse (AHU)
UMR MD2
R Guieu (PU-PH)
PJ Lejeune (MCU-PH)
G Mottola (MCU-PH)
J Fromonot (AHU)
INSERM UMR_S910
Nicolas Lévy (PU-PH)
Catherine Badens (PU-PH)
Christophe Beroud (PU-PH)
Pierre Cau (PU-PH)
Nicole Philip (PU-PH)
Martin Krahn (MCU-PH)
Karine Nguyen (MCU-PH)
Patrice Roll (MCU-PH)
Andrée Robaglia-Schlupp (MCU-PH)
Rafaelle Bernard (PH)
Nathalie Bonello-Palot (PH)
Annachiara De Sandre-Giovanolli (PH)
Sabine Sigaudy (PH)
Elise Kaspi (AHU)
Nathalie Banzet (Ingénieur AP-HM)
Inserm U1076
Nathalie Bardin (MCU-PH)
Inserm U1067/CNRS U7333
Pierre Bongrand (PU-PH)
Philippe Robert (MCU-PH)
Joanna Vitte (MCU-PH)
Cnrs U7286
José Boucraut (MCU-PH)
CNRS U 7259
Sophie Desplat-Jego (MCU-PH)
Inserm U1104/CNRS U7280
Eric Vivier (PU-PH)
Frédéric Vely (MCU-PH)
CRN2M, UMR 7286
Alain Enjalbert (PU-PH)
Anne Barlier (PU-PH)
Amapola Autillo-Touati (PU-PH) JeanLouis Berge Lefranc (MCU-PH)
A Saveanu (MCU-PH)
INSERM 1072
Jean Gabert (PU-PH)
Annie Lévy-Mozziconnacci (MCU-PH)
UMR 1076
Françoise Dignat-George (PU-PH)
Florence Sabatier (PU-PH)
2/21
Romaric Lacroix (MCU-PH)
Pascale Paul
Sylvie Cointe
SERVICES HOSPITALIERS
INTITULÉ : Service de Transfert d’Oncologie Biologique
RESPONSABLE : Pr L’Houcine OUAFIK
DISCIPLINE : Oncologie Biologique
INTITULÉ : Département de Génétique Médicale
RESPONSABLE : Pr Nicolas LEVY
DISCIPLINE : Génétique
INTITULÉ : Service de Biologie Cellulaire
RESPONSABLE : Dr Patrice ROLL
DISCIPLINE : Biologie Cellulaire
INTITULÉ : Laboratoire d'Immunologie
RESPONSABLE : Pr Pierre BONGRAND
DISCIPLINE : Immunologie
INTITULÉ : Laboratoire de Biochimie
RESPONSABLE : Pr Henri PORTUGAL
DISCIPLINE : Biochimie
INTITULÉ : Laboratoire de Biochimie et Biologie Moléculaire
RESPONSABLE : Pr Régis GUIEU
DISCIPLINE : Biochimie
INTITULÉ : Biochimie et Biologie Moléculaire.
RESPONSABLE : Pr Jean GABERT
DISCIPLINE : Biochimie et Biologie Moléculaire
INTITULÉ : laboratoire de Biologie Moléculaire, Hôpital de la Conception
RESPONSABLE : Pr Alain ENJALBERT
DISCIPLINE : Biologie Moléculaire
INTITULÉ : Service d’Hématologie et de Biologie Vasculaire
RESPONSABLE : Pr Françoise DIGNAT - GEORGE
DISCIPLINE : Hématologie, Immunologie, Biologie Vasculaire
INTITULÉ : Pharmacocinétique et toxicologie
RESPONSABLE : Pr Bruno LACARELLE
DISCIPLINE : Pharmacocinétique, Toxicologie
INTITULÉ : Service d’Hématologie Hôpital Nord et Hôpital de la Timone
RESPONSABLE : Pr Pierre-Emmanuel MORANGE
DISCIPLINE : Hématologie
INTITULÉ : Service de Pharmacologie Clinique Hôpital de la Timone et Hôpitaux Sud
RESPONSABLE : Pr Olivier BLIN
DISCIPLINE : Pharmacologie
INTITULÉ : Service Pharmacologie Clinique CAP Hôpitaux Sud
RESPONSABLE : Pr Nicolas SIMON
DISCIPLINE : Pharmacologie
3/21
PUBLICATIONS ANNÉE 2013
1
Abaeva AA, Canault M, Kotova YN, Obydennyy SI, Yakimenko AO, Podoplelova NA, Kolyadko VN,
Chambost H, Mazurov AV, Ataullakhanov FI, Nurden AT, Alessi MC, Panteleev MA. Procoagulant
platelets form anα-granule protein-covered 'cap' on their surface that promotes their attachment
to aggregates. J Biol Chem. 2013;288:29621-32 (IF = 4.651)
2
Ambrosi P, Kreitmann B, Cohen W, Habib G, Morange P Anticoagulation with a new oral
anticoagulant in heart transplant recipients.Int J Cardiol. 2013;168:4452-3 (IF = 6.175)
3
Amiot MJ, Romier B, Dao TM, Fanciullino R, Ciccolini J, Burcelin R, Pechere L, Emond C, Savouret
JF, Seree E. Optimization of trans-Resveratrol bioavailability for human therapy. Biochimie. 2013
Jun;95(6):1233-8.
4
André F, Ciccolini J, Spano JP, Penault-Llorca F, Mounier N, Freyer G, Blay JY, Milano G.
Personalized medicine in oncology: where have we come from and where are we going?
Pharmacogenomics. 2013 Jun;14(8):931-9. doi: 10.2217/pgs.13.79.
5
Ayach L, Curti C, Montana M, Pisano P, Vanelle P. Actualités dans le traitement étiologique de la
sclérose latérale amyotrophique. Amyotrophic lateral sclerosis: Update on etiological treatment
Thérapie. Vol. 68, No. 2 (Mars-Avril 2013) : 93
6
Bakour S, Touati A, Sahli F, Ameur AA, Haouchine D, Rolain JM. Antibiotic resistance determinants
of multidrug-resistant Acinetobacter baumannii clinical isolates in Algeria. Diagn Microbiol Infect
Dis. 2013 Aug;76(4):529-31.
7
Barbieri F, Albertelli M, Grillo F, Mohamed A, Saveanu A, Barlier A, Ferone D, Florio T.
Neuroendocrine tumors: insights into innovative therapeutic options andrational development of
targeted therapies. Drug Discov Today. 2013 Oct 27. piiS1359-6446(13)00382-6. doi:
10.1016/j.drudis.2013.10.015. [Epub ahead of print] PubMed PMID: 24171952.
8
Barbolosi D, Ciccolini J, Meille C, Elharrar X, Faivre C, Lacarelle B, André N, Barlesi F. Metronomics
chemotherapy: time for computational decision support. Cancer Chemother Pharmacol. 2014
Sep;74(3):647-52.
9
Barlesi F, Tomasini P, Fina F, Secq V, Greillier L, Nanni-Metellus I, Garcia S, Ouafik L. Regional
molecular genetics centers in thoracic oncology: what and who should be tested?. Bull Cancer.
2013;100:737-41. Ait-Belkacem R, Calligaris D, Sellami L, Villard C, Granjeaud S, Schembri T,
Berenguer C, Ouafik L, Figarella-Branger D, Chinot O, Lafitte D. Tubulin isoforms identified in the
brain by MALDI in-source decay. J Proteomics. 2013;79:172-9.
10
Baujat G, Huber C, El Hokayem J, Caumes R, Do Ngoc Thanh C, David A, Delezoide AL, DieuxCoeslier A, Estournet B, Francannet C, Kayirangwa H, Lacaille F, Le Bourgeois M, Martinovic J,
Salomon R, Sigaudy S, Malan V, Munnich A, Le Merrer M, Le Quan Sang KH, Cormier-Daire
V.Asphyxiating thoracic dysplasia: clinical and molecular review of 39 families. J Med Genet. 2013
Feb;50(2):91-8
11
Baumstarck K, Bonello L, Dignat-George F, Sabatier F.Mobilization of CD34+KDR+ endothelial
progenitor cells predicts target lesion revascularization: a reply to a rebuttal concerning power
and sample size calculation. J Thromb Haemost. 2013 Feb;11(2):398-9.
12
Ben Lassoued A1, Beaufils N, Dales JP, Gabert J. Hypoxia-inducible factor-1α as prognostic
marker. Expert Opin Med Diagn. 2013 Jan;7(1):53-70.
4/21
13
Berenguer-Daizé C, Boudouresque F, Bastide C, Tounsi A, Benyahia Z, Acunzo J, Dussault N,
Delfino C, Baeza N, Daniel L, Cayol M, Rossi D, El Battari A, Bertin D, Mabrouk K, Martin PM,
Ouafik L. Adrenomedullin blockade suppresses growth of human hormone-independent prostate
tumor xenograft in mice. Clin Cancer Res. 2013; 19(22):6138-50. Nouguerède E, Berenguer C,
Garcia S, Bennani B, Delfino C, Nanni I, Dahan L, Gasmi M, Seitz J-F, Martin P-M, Ouafik L.
Expression of Adrenomedullin in human colorectal tumors and its role in cell growth and invasion
in vitro and in xenografts growth in vivo. Cancer Medicine. 2013; 2(2):196-207.
14
Bertin D, Grimaud JC, Lesavre N, Benelmouloud C, Desjeux A, Garcia S, et al. Targeting tissular
immune response improves diagnostic performance of anti-Saccharomyces cerevisiae antibodies
(ASCA) in Crohn's disease. PLoS One 2013;8:e80433.
15
Bertin D, Jourde-Chiche N, Bongrand P, Bardin N. Original approach for automated quantification
of antinuclear autoantibodies by indirect immunofluorescence. Clin Dev Immunol
2013;2013:182172.
16
Bertin D, Jourde-Chiche N, Bongrand P, Bardin N. Original approach for automated quantification
of antinuclear autoantibodies by indirect immunofluorescence. Clin Dev Immunol. 2013 ; 2013 :
182 172. doi: 10.1155/2013/182172. Epub 2013 Dec 18.
17
Bertin D, Stephan D, Khrestchatisky M, Desplat-Jégo S. Is TWEAK a Biomarker for
Autoimmune/Chronic Inflammatory Diseases? Front Immunol 2013;4:489.
18
Bessoles S, Angelov GS, Back J, Leclercq G, Vivier E, Held W. Education of murine NK cells
requires both cis and trans recognition of MHC class I molecules. J Immunol 2013;191:5044-51.
19
Biroccio A, Cherfils-Vicini J, Augereau A, Pinte S, Bauwens S, Ye J, et al. TRF2 inhibits a cellextrinsic pathway through which natural killer cells eliminate cancer cells. Nat Cell Biol
2013;15:818-28.
20
Blons H, Rouleau E, Charrier N, Chatellier G, Côté JF, Pages JC, de Fraipont F, Boyer JC, Merlio JP,
Morel A, Gorisse MC, de Cremoux P, Leroy K, Milano G, Ouafik L, Merlin JL, Le Corre D,
Aucouturier P, Sabourin JC, Nowak F, Frebourg T, Emile JF, Durand-Zaleski I, Laurent-Puig P;
MOKAECM Collaborative Group. Performance and cost efficiency of KRAS mutation testing for
metastatic colorectal cancer in routine diagnosis: the MOKAECM study, a nationwide experience.
PLoS One. 2013;8(7):e68945.
21
Bonello L, Frère C, Paganelli F, Laine M. The impact of the environment on diseases and drugs. J
Am Coll Cardiol. 2013 Aug 6;62(6):513-5.
22
Bonello L, Laine M, Baumstarck K, Fernandez J, Maillard L, Peyrol M, Bessereau J, Aradi D,
Camilleri E, Roubille F, Piot C, Paganelli F, Camoin-Jau L, Dignat-George F. A randomized trial of
platelet reactivity monitoring-adjusted clopidogrel therapy versus prasugrel therapy to reduce
high on-treatment platelet reactivity. Int J Cardiol. 2013 Oct 9;168(4):4244-8.
23
Bonello L, Laine M, Kipson N, Mancini J, Helal O, Fromonot J, Gariboldi V, Condo J, Thuny F, Frere
C, Camoin-Jau L, Paganelli F, Dignat-George F, Guieu R. Ticagrelor increases adenosine plasma
concentration in patients with an acute coronary syndrome. J Am Coll Cardiol. 2014 Mar
11;63(9):872-7. doi: 10.1016/j.jacc.2013.09.067. Epub 2013 Nov 27. PubMed PMID: 24291273.
24
Bonello L, Paganelli F, Laine M. Pharmacological interactions: the next frontier ? JACC Cardiovasc
Interv. 2013 Feb;6(2):180-1.
25
Bordignon B, Chiron J, Fontés M. Ascorbic acid derivatives as a new class of antiproliferative
molecules.Cancer Lett. 2013;338:317-27 (IF = 4.258)
26
Bordignon B, Mones S, Rahman F, Chiron J, Peiretti F, Vidal N, Fontes M. A derivative of ascorbic
acid modulates cAMP production. Biochem Biophys Res Commun. 2013;439:137-41 (IF = 2.406)
27
Boubred F, Saint-Faust M, Buffat C, Ligi I, Grandvuillemin I, Simeoni U. Developmental Origins of
Chronic Renal Disease: An Integrative Hypothesis. Int J Nephrol. 2013;2013:346067. Epub 2013
Aug 29.
5/21
28
Bourgeois C, Douplat M, Guieu R, Pradel V, Fromonot J, Bonnet JL, Alazia M. [Interest of the
combination of high-sensitivity troponine and copeptin in diagnosis of non ST elevation myocardial
infarction]. Ann Biol Clin (Paris). 2013 Sep-Oct;71(5):545-54.
29
Bricaire L, Odou MF, Cardot-Bauters C, Delemer B, North MO, Salenave S, Vezzosi D, Kuhn JM,
Murat A, Caron P, Sadoul JL, Silve C, Chanson P, Barlier A, Clauser E, Porchet N, Groussin L; GTE
Group. Frequent large germline HRPT2deletions in a French National cohort of patients with
primaryhyperparathyroidism. J Clin Endocrinol Metab. 2013 Feb;98(2):E403-8. doi:
10.1210/jc.2012-2789. Epub 2013 Jan 4. Erratum in: J Clin Endocrinol Metab. 2013
Apr;98(4):1766. PubMed PMID: 23293331.
30
Brodovitch A, Bongrand P, Pierres A. T lymphocytes sense antigens within seconds and make a
decision within one minute. J Immunol 2013;191:2064-71.
31
Broucqsault N1, Morere J, Gaillard MC, Dumonceaux J, Torrents J, Salort-Campana E, Maues De
Paula A, Bartoli M, Fernandez C, Chesnais AL, Ferreboeuf M, Sarda L, Dufour H, Desnuelle C,
Attarian S, Levy N, Nguyen K, Magdinier F, Roche S.Dysregulation of 4q35- and muscle-specific
genes in fetuses with a short D4Z4 array linked to facio-scapulo-humeral dystrophy.Hum Mol
Genet. 2013 Oct 15;22(20):4206-14.
32
Busa T, Chabrol B, Perret O, Longy M, Philip N. Novel PTEN germline mutation in a family with
mild phenotype: difficulties in genetic counseling. Gene. 2013 Jan 10;512(2):194-7. doi:
10.1016/j.gene.2012.09.134. Epub 2012 Nov 2. PubMed PMID: 23124040.
33
Cacciagli P, Sutera-Sardo J, Borges-Correia A, Roux JC, Dorboz I, Desvignes JP, Badens C,
Delepine M, Lathrop M, Cau P, Lévy N, Girard N, Sarda P, Boespflug-Tanguy O, Villard L.
Mutations in BCAP31 cause a severe X-linked phenotype with deafness, dystonia, and central
hypomyelination and disorganize the Golgi apparatus. Am J Hum Genet. 2013 Sep 5;93(3):57986.
34
Calfee MW, Rose LJ, Morse S, Mattorano D, Clayton M, Touati A, Griffin-Gatchalian N, Slone C,
McSweeney N. Comparative evaluation of vacuum-based surface sampling methods for collection
of Bacillus spores. J Microbiol Methods. 2013 Dec;95(3):389-96.
35
Callier P, Aral B, Hanna N, Lambert S, Dindy H, Ragon C, Payet M, Collod-Beroud G, Carmignac V,
Delrue M, Goizet C, Philip N, Busa T, Dulac Y, Missotte I, Sznajer Y, Toutain A, Francannet C,
Megarbane A, Julia S, Edouard T, Sarda P, Amiel J, Lyonnet S, Cormier-Daire V, Gilbert B,
Jacquette A, Heron D, Collignon P, Lacombe D, Morice-Picard F, Jouk P, Cusin V, Willems M,
Sarrazin E, Amarof K, Coubes C, Addor M, Journel H, Colin E, Khau Van Kien P, Baumann C,
Leheup B, Martin-Coignard D, Doco-Fenzy M, Goldenberg A, Plessis G, Thevenon J, Pasquier L,
Odent S, Vabres P, Huet F, Marle N, Mosca-Boidron A, Mugneret F, Gauthier S, Binquet C,
Thauvin-Robinet C, Jondeau G, Boileau C, Faivre L. Systematic molecular and cytogenetic
screening of 100 patients with marfanoid syndromes and intellectual disability. Clin Genet. 2013
Mar 18. doi: 10.1111/cge.12094. [Epub ahead of print] PubMed PMID: 23506379.
36
Carrieri MP, Lions C, Sogni P, Winnock M, Roux P, Mora M, Bonnard P, Salmon D, Dabis F, Spire B;
ANRS CO13 HEPAVIH Study Group. Association between elevated coffee consumption and daily
chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the
ANRS CO13 HEPAVIH cohort study. J Hepatol. 2014 Jan;60(1):46-53. doi:
10.1016/j.jhep.2013.08.014. Epub 2013 Aug 24.
37
Cayla G, Cuisset T, Silvain J, O'Connor SA, Kerneis M, Castelli C, Quilici J, Bonnet JL, Alessi MC,
Morange PE, Collet JP, Montalescot G. Prasugrel monitoring and bleeding in real world patients.
Am J Cardiol. 2013;11138-44. (IF = 3.425)
38
Cayla G, Morange PE, Chambost H, Schved JF. Management of cardiovascular disease in
haemophilia.Thromb Res. 2013;132:8-14 (IF = 2.372)
39
Chabbert-Buffet N, Guigues B, Trillot N, Biron C, Morange P, Pernod G, Scheffler M, Brugere S,
Hedon B. [DVT and combined oral contraceptives: update of the pluridisciplinary CNGOF-FNCGMGEHT-SFMV group].J Gynecol Obstet Biol Reprod (Paris). 2013;42:309-15 (IF = 0.448)
6/21
40
Chassaing N1, Causse A, Vigouroux A, Delahaye A, Alessandri JL, Boespflug-Tanguy O, BouteBenejean O, Dollfus H, Duban-Bedu B, Gilbert-Dussardier B, Giuliano F, Gonzales M, HolderEspinasse M, Isidor B, Jacquemont ML, Lacombe D, Martin-Coignard D, Mathieu-Dramard M,
Odent S, Picone O, Pinson L, Quelin C, Sigaudy S, Toutain A, Thauvin-Robinet C, Kaplan J, Calvas
P. Molecular findings and clinical data in a cohort of 150 patients with
anophthalmia/microphthalmia.Clin Genet. 2013 Sep 10.
41
Ciccolini J, Fanciullino R, Milano G. Predicting survival of gastric cancer patients treated with 5fluorouracil-based regimen: falling again on TP53 Pharmacogenomics 07/2013; 14(10):11371138.
42
Ciccolini J, Peters GJ, Giovannetti E. Gender, cytidine deaminase, and 5-aza/decitabine--letter.
Clin Cancer Res. 2013 Jun 1;19(11):3105.
43
Colson P, Bregigeon S, Tourres C, Solas C, Poizot-Martin I, Tamalet C. Relapse of hepatitis C virus
after 14 months of sustained virological response following pegylated-interferon alpha plus
ribavirin therapy in a human immunodeficiency virus type 1 infected patient. J Clin Virol. 2013
Sep;58(1):309-14.
44
Cordier C, Taris N, De Pauw A, Sobol H, Philip N, Voelckel MA. French professionals in genetic
counselor careers. J Genet Couns. 2013 Dec;22(6):844-8. doi: 10.1007/s10897-013-9599-x.
Epub 2013 May 21. PubMed PMID: 23689926.
45
Cottereau E, Mortemousque I, Moizard MP, Bürglen L, Lacombe D, Gilbert-Dussardier B, Sigaudy
S, Boute O, David A, Faivre L, Amiel J, Robertson R, Viana Ramos F, Bieth E, Odent S, Demeer B,
Mathieu M, Gaillard D, Van Maldergem L, Baujat G, Maystadt I, Héron D, Verloes A, Philip N,
Cormier-Daire V, Frouté MF, Pinson L, Blanchet P, Sarda P, Willems M, Jacquinet A, Ratbi I, Van
Den Ende J, Lackmy-Port Lis M, Goldenberg A, Bonneau D, Rossignol S, Toutain A..Phenotypic
spectrum of Simpson-Golabi-Behmel syndrome in a series of 42 cases with a mutation in GPC3
and review of the literature. Am J Med Genet C Semin Med Genet. 2013 May;163C(2):92-105
46
Courcet JB, Faivre L, Michot C, Burguet A, Perez-Martin S, Alix E, Amiel J, Baumann C, Cordier
MP, Cormier-Daire V, Delrue MA, Gilbert-Dussardier B, Goldenberg A, Jacquemont ML, Jaquette A,
Kayirangwa H, Lacombe D, Le Merrer M, Toutain A, Odent S, Moncla A, Pelet A, Philip N, Pinson L,
Poisson S, Kim-Han le QS, Roume J, Sanchez E, Willems M, Till M, Vincent-Delorme C, Mousson
C, Vinault S, Binquet C, Huet F, Sarda P, Salomon R, Lyonnet S, Sanlaville D, Geneviève D.
Clinical and molecular spectrum of renal malformations in Kabuki syndrome. J Pediatr. 2013
Sep;163(3):742-6. doi: 10.1016/j.jpeds.2013.02.032. Epub 2013 Mar 25. PubMed PMID:
23535010.
47
Cristofaro B, Shi Y, Faria M, Suchting S, Leroyer AS, Trindade A, Duarte A, Zovein AC, IruelaArispe ML, Nih LR, Kubis N, Henrion D, Loufrani L, Todiras M, Schleifenbaum J, Gollasch M,
Zhuang ZW, Simons M, Eichmann A, le Noble F. Dll4-Notch signaling determines the formation of
native arterial collateral networks and arterial function in mouse ischemia models. Development.
2013 Apr;140(8):1720-9.
48
Cuisset T, Grosdidier C, Loundou AD, Quilici J, Loosveld M, Camoin L, Pankert M, Beguin S,
Lambert M, Morange PE, Bonnet JL, Alessi MC. Clinical Implications of Very Low On-Treatment
platelet reactivity in patients treated with thienopyridine: The POBA study (Predictor of bleedings
with antiplatelet drugs).JACC Cardiovasc Interv. 2013;6:854-63 (IF = 6.552)
49
Cuisset T, Quilici J, Morange PE, Bonnet JL, Alessi MC. Predictors of long-term high on-treatment
platelet reactivity in clopidogrel-treated patients undergoing coronary stenting for acute coronary
syndrome.Int J Cardiol. 2013 ;168:1565-6. (IF = 6.175)
50
Cuisset T,Cayla G, Quilici J, Pankert M, Deharo P, Bonnet G, Grosdidier C, Beguin S, Morange P,
Bonnet JL, Alessi MC.Off-label use of prasugrel in stable coronary artery disease is associated with
greater degree of platelet inhibition compared with use after acute coronary syndrome. Int J
Cardiol. 2013 ;168:2988-9 (IF = 6.175)
51
Cuny T, Barlier A. The significance of MEN1 mutations in pituitary carcinomas. Biomark Med. 2013
Aug;7(4):567-9. doi: 10.2217/bmm.13.69. PubMed PMID: 23905891.
7/21
52
Cuny T, Pertuit M, Sahnoun-Fathallah M, Daly A, Occhi G, Odou MF, Tabarin A, Nunes ML,
Delemer B, Rohmer V, Desailloud R, Kerlan V, Chabre O, Sadoul JL, Cogne M, Caron P, CortetRudelli C, Lienhardt A, Raingeard I, Guedj AM, Brue T, BeckersA, Weryha G, Enjalbert A, Barlier A.
Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't
forget MEN1 genetic analysis. Eur J Endocrinol. 2013 Mar 15;168(4):533-41. doi: 10.1530/EJE12-0763. Print 2013Apr. PubMed PMID: 23321498.
53
D. Barbolosi A. Benabdallah S. Benzekry J. Ciccolini C. Faivre F. Hubert F. Verga B. You A
Mathematical Model for Growing Metastases on Oncologists’s Service. In book: Computational
Surgery and Dual Training, Publisher: SPRINGER, Editors: Garbey, M, Bass, B.L., Collet, C,
Mathelin, M, Tran-Son-Tay, R. Eds, pp.331-338
54
Daumas A, Eraud J, Hautier A, Sabatier F, Magalon G, Granel B.Interests and potentials of adipose
tissue in scleroderma] Rev Med Interne. 2013 Dec;34(12):763-9
55
Daumas A, Grob A, Faucher B, Melenotte C, Rossi P, Jean E, et al. Une cause rare de cervicalgie
au cours d'une sclérodermie systémique. Rev Med Interne 2013;34:719-20.
56
Daumas A, Mélenotte C, Jimenez S, Rossi P, Jean E, Figarella-Branger D, et al. Des douleurs des
membres supérieurs après un effort intense. Rev Med Interne 2013.
57
Deharo JC, Guieu R, Mechulan A, Peyrouse E, Kipson N, Ruf J, Gerolami V, Devoto G, Marrè V,
Brignole M. Syncope without prodromes in patients with normal heart and normal
electrocardiogram: a distinct entity. J Am Coll Cardiol. 2013Sep 17;62(12):1075-80. doi:
10.1016/j.jacc.2013.05.060. Epub 2013 Jun 27. PubMed PMID: 23810895.
58
Deharo P, Bassez C, Bonnet G, Pankert M, Quilici J, Lambert M, Verdier V, Morange P, Alessi MC,
Bonnet JL, Cuisset T. Prasugrel versus ticagrelor in acute coronary syndrome: a randomized
comparison. Int J Cardiol. 2013;170:e21-2. (IF = 6.175)
59
Deharo P, Pons C, Pankert M, Bonnet G, Quilici J, Grosdidier C, Beguin S, Morange P, Alessi MC,
Bonnet JL, Cuisset T. Effectiveness of switching 'hyper responders' from Prasugrel to Clopidogrel
after acute coronary syndrome: The POBA (Predictor of Bleeding with Antiplatelet drugs) SWITCH
study.Int J Cardiol. 2013;168:5004-5 (IF = 6.175)
60
Delgado-Lista J, Perez-Martinez P, Garcia-Rios A, Phillips CM, Hall W, Gjelstad IM, Lairon D, Saris
W, Kieć-Wilk B, Karlström B, Drevon CA, Defoort C, Blaak EE, Dembinska-Kieć A, Risérus U,
Lovegrove JA, Roche HM, Lopez-Miranda J. A gene variation (rs12691) in the CCAT/enhancer
binding protein α modulates glucose metabolism in metabolic syndrome.Nutr Metab Cardiovasc.
Dis. 2013;23:417-23 (IF = 3.875)
61
Delio M, Guo T, McDonald-McGinn DM, Zackai E, Herman S, Kaminetzky M, Higgins AM, Coleman
K, Chow C, Jalbrzikowski M, Bearden CE, Bailey A, Vangkilde A, Olsen L, Olesen C, Skovby F,
Werge TM, Templin L, Busa T, Philip N, Swillen A, Vermeesch JR, Devriendt K, Schneider M,
Dahoun S, Eliez S, Schoch K, Hooper SR, Shashi V, Samanich J, Marion R, van Amelsvoort T, Boot
E, Klaassen P, Duijff SN, Vorstman J, Yuen T, Silversides C, Chow E, Bassett A, Frisch A,
Weizman A, Gothelf D, Niarchou M, van den Bree M, Owen MJ, Suñer DH, Andreo JR, Armando M,
Vicari S, Digilio MC, Auton A, Kates WR, Wang T, Shprintzen RJ, Emanuel BS, Morrow BE.
Enhanced maternal origin of the 22q11.2 deletion in velocardiofacial and DiGeorge syndromes.
Am J Hum Genet. 2013 Mar 7;92(3):439-47. doi: 10.1016/j.ajhg.2013.01.018. Epub 2013 Feb
28. Erratum in: Am J Hum Genet. 2013 Apr 4;92(4):637. Jarlbrzkowski, Maria [corrected to
Jalbrzikowski, Maria]. PubMed PMID: 23453669; PubMed Central PMCID: PMC3591861.
62
Dinarello CA, Novick D, Kim S, Kaplanski G. Interleukin-18 and IL-18 Binding Protein. Front
Immunol. 2013 Oct 8;4:289.
63
Djoudi F, Bonura C, Benallaoua S, Touati A, Touati D, Aleo A, Cala C, Fasciana T, Mammina C.
Panton-Valentine leukocidin positive sequence type 80 methicillin-resistant Staphylococcus aureus
carrying a staphylococcal cassette chromosome mec type IVc is dominant in neonates and
children in an Algiers hospital. New Microbiol. 2013 Jan;36(1):49-55.
8/21
64
Dreux S, Nguyen C, Czerkiewicz I, Schmitz T, Azria E, Fouré MA, Muller F; ABA Study Group.
Down syndrome maternal serum marker screening after 18 weeks of gestation: a countrywide
study. Am J Obstet Gynecol. 2013 May;208(5):397.e1-5.
65
Dumètre A, Dubey JP, Ferguson DJ, Bongrand P, Azas N, Puech PH. Mechanics of the Toxoplasma
gondii oocyst wall. Proc Natl Acad Sci U S A 2013;110:11535-40.
66
Dupont J, Fromonot J, Franceschi F, Deharo JC, Boucraut J, Quilici J, Bonnet JL, Monserrat C,
Guieu R. A case of false positive troponin elevation: role of the biological laboratory. Int J Cardiol.
2013 4 :125-127
67
DYSCERNE expert panel. Dysmorphology at a distance: results of a web-based diagnostic service.
Eur J Hum Genet. 2014 Mar;22(3):327-32. doi: 10.1038/ejhg.2013.137. Epub 2013 Jul 10.
PubMed PMID: 23838594.
68
Evrard A, Lacarelle B, Ciccolini J. Severe or lethal toxicities with nucleosidic analogs: time for
action. Pharmacogenomics. 2013 Feb;14(3):227-30. doi: 10.2217/pgs.12.208. No abstract
available.
69
Fanciullino R, Ciccolini J, Milano G. Challenges, expectations and limits for nanoparticles-based
therapeutics in cancer: a focus on nano-albumin-bound drugs. Crit Rev Oncol Hematol. 2013
Dec;88(3):504-13. doi: 10.1016/j.critrevonc.2013.06.010. Epub 2013 Jul 18. Review.
70
Fanciullino R, Mollard S, Correard F, Giacometti S, Serdjebi C, Iliadis A, Ciccolini J. Biodistribution,
Tumor Uptake and Efficacy of 5-FU-Loaded Liposomes: Why Size Matters. Pharm Res. 2014 Apr
22. [Epub ahead of print]
71
Fanciullino R, Mollard S, Giacometti S, Berda-Haddad Y, Chefrour M, Aubert C, Iliadis A, Ciccolini
J. In vitro and in vivo evaluation of lipofufol, a new triple stealth liposomal formulation of
modulated 5-fu: impact on efficacy and toxicity. Pharm Res. 2013 May;30(5):1281-90. doi:
10.1007/s11095-012-0967-2. Epub 2013 Feb 6.
72
Farnault L, Chambost H, Michel G, Thuret I, de Saint Basile G, Fischer A, et al. Persistence of
natural killer cells with expansion of a hypofunctional CD56-CD16+KIR+NKG2C+ subset in a
patient with atypical Janus kinase 3-deficient severe combined immunodeficiency. J Allergy Clin
Immunol 2013;131:1230-3, 1233.e1-2.
73
Fernandez C, Bardin N, De Paula AM, Salort-Campana E, Benyamine A, Franques J, et al.
Correlation of clinicoserologic and pathologic classifications of inflammatory myopathies: study of
178 cases and guidelines for diagnosis. Medicine (Baltimore) 2013;92:15-24.
74
Figarella-Branger D, Raverot G; members of HYPOPRONOS, Barlier A, Bernier M, Bonnet F,
Borson-Chazot F, Brassier G, Caulet-Maugendre S, Chabre O, Chanson P, Cottier JF, Delemer B,
Delgrange E, Di Tommaso L, Eimer S, Gaillard S, Jan M, Girard JJ, Lapras V, Loiseau H, Passagia
JG, Patey M, Penfornis A, Poirier JY, Perrin G, Tabarin A. A new prognostic clinicopathological
classification ofpituitary adenomas: a multicentric case-control study of 410 patients with 8years
post-operative follow-up. Acta Neuropathol. 2013 Jul;126(1):123-35. doi: 10.1007/s00401-0131084-y. Epub 2013 Feb 12. PubMed PMID: 23400299.
75
Firth MA, Madera S, Beaulieu AM, Gasteiger G, Castillo EF, Schluns KS, et al. Nfil3-independent
lineage maintenance and antiviral response of natural killer cells. J Exp Med 2013;210:2981-90.
76
Fournier N, Toesca R, Bessereau J, Champenois A, Mazille A, Luigi S, Yvorra S, Paganelli F, Brun
PM, Michelet P, Meyran D, Auffray JP, Bonello L. Ticagrelor or prasugrel for pre-hospital protocols
in STEMI ? Int J Cardiol. 2013 Oct 9;168(4):4566-7.
77
Franceschi F, By Y, Peyrouse E, Fromonot J, Gerolami V, Kipson N, Boussuges A, Brignole M,
Fenouillet E, Deharo JC, Ruf J, Guieu R. A2A adenosine receptorfunction in patients with
vasovagal syncope. Europace. 2013 Sep;15(9):1328-32. doi: 10.1093/europace/eut066. Epub
2013 Apr 17. PubMed PMID: 23594931.
9/21
78
Frere C, Mercier-Bataille D, Suchon P, Aillaud MF. Le TCA, what else ? Spectra Biologie. 2013 Mar;
199 : 41-48
79
G. Hache. La fibromyalgie. Pharmacie clinique – Le Moniteur Hospitalier 2013 ; 259
80
Gabriel S, Blanchet EM, Sebag F, Chen CC, Fakhry N, Deveze A, Barlier A, Morange I, Pacak K,
Taïeb D. Functional characterization of nonmetastaticparaganglioma and pheochromocytoma by
(18) F-FDOPA PET: focus on missed lesions. Clin Endocrinol (Oxf). 2013 Aug;79(2):170-7. doi:
10.1111/cen.12126. Epub 2013May 6. PubMed PMID: 23230826; PubMed Central PMCID:
PMC3610811.
81
Garand R, Beldjord K, Cavé H, Fossat C, Arnoux I, Asnafi V, Bertrand Y,Boulland ML, Brouzes C,
Clappier E, Delabesse E, Fest T, Garnache-Ottou F, Huguet F, Jacob MC, Kuhlein E, Marty-Grès S,
Plesa A, Robillard N, Roussel M, Tkaczuk J,Dombret H, Macintyre E, Ifrah N, Béné MC, Baruchel A.
Flow cytometry and IG/TCRquantitative PCR for minimal residual disease quantitation in acute
lymphoblasticleukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC
and GRAALL. Leukemia. 2013 ;27:370-6.
82
Gentile S, Beauger D, Speyer E, Jouve E, Dussol B, Jacquelinet C, Briancon S. Factors associated
with health-related quality of life in renal transplant recipients: results of a national survey in
France. Health Qual Life Outcomes 2013 May 30;11(1):88.
83
Goncalves TM, Alhanout K, Nicolay A, Dubus JC, de Santana DP, Andrieu V Comparative in vitro
performance of three small-volume valved holding chambers with beclomethasone/formoterol
pressurized metered dose inhaler. J Aerosol Med Pulm Drug Deliv, 2013, 26(4): 223-7.
84
Gondouin B, Cerini C, Dou L, Sallée M, Duval-Sabatier A, Pletinck A, Calaf R, Lacroix R, JourdeChiche N, Poitevin S, Arnaud L, Vanholder R, Brunet P, Dignat-George F, Burtey S. Indolic uremic
solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor
pathway. Kidney Int. 2013 Oct;84(4):733-44.
85
Grados A, Ebbo M, Boucraut J, Vély F, Aucouturier P, Rigolet A, et al. Serum Immunoglobulin Free
Light Chain Assessment in IgG4-Related Disease. Int J Rheumatol 2013;2013:426759.
86
Gravier G, Delliaux S, Ba A, Delpierre S, Guieu R, Jammes Y. Early ventilation-heart rate
breakpoint during incremental cycling exercise. Int J Sports Med. 2014 Mar;35(3):191-8.
87
Gravier G, Delliaux S, Delpierre S, Guieu R, Jammes Y. Inter-individual differences in breathing
pattern at high levels of incremental cycling exercise in healthy subjects. Respir Physiol Neurobiol.
2013 Oct 1;189(1):59-66. doi: 10.1016/j.resp.2013.06.027.
88
Gravier G, Steinberg JG, Lejeune PJ, Delliaux S, Guieu R, Jammes Y. Exercise-induced oxidative
stress influences the motor control during maximal incremental cycling exercise in healthy
humans. Respir Physiol Neurobiol. 2013 May 1;186(3):265-72
89
Greliche N, Germain M, Lambert JC, Cohen W, Bertrand M, Dupuis AM, Letenneur L, Lathrop M,
Amouyel P, Morange PE, Trégouët DA. A genome-wide search for common SNP x SNP interactions
on the risk of venous thrombosis. BMC Med Genet. 2013;14:36 (IF = 2.536)
90
Grison S, Favé G, Maillot M, Manens L, Delissen O, Blanchardon E, Banzet N, Defoort C, Bott R,
Dublineau I, Aigueperse J, Gourmelon P, Martin JC and Souidi M. Metabolomics identifies a
biological response to chronic low-dose natural uranium contamination in urine samples.
Metabolomics 2013;9:1168-1180 (IF = 4.505)
91
Grosdidier C, Quilici J, Loosveld M, Camoin L, Moro PJ, Saut N, Gaborit B, Pankert M, Cohen W,
Lambert M, Beguin S, Morange PE, Bonnet JL, Alessi MC, Cuisset T. Effect of cyp2C19*2 and *17
genetic variants on platelet response to clopidogrel and prasugrel maintenance dose and relation
to bleeding complications. Am J Cardiol. 2013;111:985-90 (IF = 3.425)
10/21
92
Gullett BK, Tabor D, Bertrand A, Touati A. Quality control for sampling of PCDD/PCDF emissions
from open combustion sources. Chemosphere. 2013 Sep;93(3):494-8.
93
Guy J, Antony-Debré I, Benayoun E, Arnoux I, Fossat C, Le Garff-Tavernier M, Raimbault A,
Imbert M, Maynadié M, Lacombe F, Béné MC, Wagner-Ballon O; GEIL(Groupe d'Etude
Immunologique des Leucémies). Flow cytometry thresholds ofmyeloperoxidase detection to
discriminate between acute lymphoblastic or myeloblastic leukaemia. Br J Haematol. 2013
161:551-5.
94
Hajji H, Gérolami R, Solas C, Moreau J, Colson P. Chronic hepatitis E resolution in a human
immunodeficiency virus (HIV)-infected patient treated with ribavirin. Int J Antimicrob Agents.
2013 Jun;41(6):595-7. doi: 10.1016/j.ijantimicag.2013.02.005.
95
Hourmant M, de Cornelissen F, Brunet P, Pavaday K, Assogba F, Couchoud C, Jacquelinet C;
registre du REIN. Access to the waiting list and renal transplantation. Nephrol Ther. 2013 Sep;9
Suppl 1:S139-66.
96
Huber C, Wu S, Kim AS, Sigaudy S, Sarukhanov A, Serre V, Baujat G, Le Quan Sang KH, Rimoin
DL, Cohn DH, Munnich A, Krakow D, Cormier-Daire. WDR34 mutations that cause short-rib
polydactyly syndrome type III/severe asphyxiating thoracic dysplasia reveal a role for the NF-κB
pathway in cilia. V.Am J Hum Genet. 2013 Nov 7;93(5):926-3
97
Imperiale A, Moussallieh FM, Sebag F, Brunaud L, Barlier A, Elbayed K, Bachellier P, Goichot B,
Pacak K, Namer IJ, Taïeb D. A new specific succinate-glutamate metabolomic hallmark in sdhxrelated paragangliomas. PLoSOne. 2013 Nov 27;8(11):e80539. doi:
10.1371/journal.pone.0080539. PubMed PMID: 24312232; PubMed Central PMCID: PMC3842321.
J Thromb Haemost. 2013;1:111-21 (IF = 6.081)
98
Jaffrain-Rea ML, Rotondi S, Turchi A, Occhi G, Barlier A, Peverelli E, Rostomyan L, Defilles C,
Angelini M, Oliva MA, Ceccato F, Maiorani O, Daly AF, Esposito V, Buttarelli F, Figarella-Branger D,
Giangaspero F, Spada A, Scaroni C, Alesse E, Beckers A. Somatostatin analogues increase AIP
expression insomatotropinomas, irrespective of Gsp mutations. Endocr Relat Cancer. 2013
Sep16;20(5):753-66. doi: 10.1530/ERC-12-0322. Print 2013 Oct. PubMed PMID: 23940012.
99
Jamilloux Y, Favier J, Pertuit M, Delage-Corre M, Lopez S, Teissier MP, Mathonnet M, Galinat S,
Barlier A, Archambeaud F. A MEN1 syndrome with aparaganglioma. Eur J Hum Genet. 2013 Jun
19. doi: 10.1038/ejhg.2013.128. [Epubahead of print] PubMed PMID: 23778871.
100
Jammes Y, Steinberg JG, Olivier M, Brerro-Saby C, Condo J, Ravailhe S, Guieu R, Delliaux S. The
mechanisms of the widespread production of phosphorylated HSP25 after fatiguing muscle
stimulation. J Exp Biol. 2013 Oct 1;216(Pt 19):3620-6.
101
Jordan S, Ruzsics Z, Mitrovi? M, Baranek T, Arapovi? J, Krmpoti? A, et al. Natural killer cells are
required for extramedullary hematopoiesis following murine cytomegalovirus infection. Cell Host
Microbe 2013;13:535-45.
102
Jouanguy E, Gineau L, Cottineau J, Béziat V, Vivier E, Casanova JL. Inborn errors of the
development of human natural killer cells. Curr Opin Allergy Clin Immunol 2013;13:589-95.
103
Joulia F, Coulange M, Lemaitre F, Costalat G, Franceschi F, Gariboldi V, Nee L, Fromonot J,
Bruzzese L, Gravier G, Kipson N, Jammes Y, Boussuges A, Brignole M, Deharo JC, Guieu R.
Plasma adenosine release is associated with bradycardia and transient loss of consciousness
during experimental breath-hold diving. Int J Cardiol. 2013 Oct 12;168(5):e138-41.
104
Jouve N, Despoix N, Espeli M, Gauthier L, Cypowyj S, Fallague K, et al. The involvement of CD146
and its novel ligand Galectin-1 in apoptotic regulation of endothelial cells. J Biol Chem
2013;288:2571-9.
11/21
105
Karsenty J, Landrier JF, Rousseau-Ralliard D, Robbez-Masson V, Margotat A,Deprez P, Lechêne P,
Grynberg A, Lairon D, Planells R, Gastaldi M. Beneficial effects of omega-3 fatty acids on the
consequences of a fructose diet are not mediated by PPAR delta or PGC1 alpha. Eur J Nutr. 2013
;52:1865-74. (IF = 3.84)
106
Kaspi E, Guillet B, Piercecchi-Marti MD, Alfaidy N, Bretelle F, Bertaud-Foucault A, Stalin J,
Rambeloson L, Lacroix R, Blot-Chabaud M, Dignat-George F, Bardin N. Identification of soluble
CD146 as a regulator of trophoblast migration: potential role in placental vascular development.
Angiogenesis. 2013 Apr;16(2):329-42.
107
Kerdiles Y, Ugolini S, Vivier E. T cell regulation of natural killer cells. J Exp Med 2013;210:1065-8.
108
Lacroix R, Desplat V, Dignat-George F et Sampol J. La leucémie lymphoïde chronique. Biochimie
Hématologie. Le moniteur d'internat 2013
109
Lacroix R, Desplat V, Dignat-George F et Sampol J. Les lymphomes. Biochimie Hématologie.
110
Lacroix R, Desplat V, Dignat-George F et Sampol J. Les syndromes mononucléosiques. Biochimie
111
Lacroix R, Dignat-George F. Microparticles : new protagonists in pericellular and intravascular
proteolysis. Seminars Thromb Haemost 2013 Feb; 39(1):33-9.
112
Lacroix R, Judicone C, Robert S, Arnaud L, Sabatier F and Dignat-George F. Chapter : Preanalytical variables. Book : Exosomes and microvesicles in health and diseases. Standford Edition
2013
113
Lacroix R, Robert S, Sabatier F and Dignat-George F. Chapter : Flow cytometry. Book : Exosomes
and microvesicles in health and diseases. Standford Edition 2013
114
Lacroix R, Sabatier F, Dignat-George F et Sampol J. La leucémie myéloïde chronique. Biochimie
115
Lacroix R., Dubois C., Leroyer A.S., Sabatier F., and Dignat-George F. Revisited role of
microparticles in arterial and venous thrombosis. J Thromb Haemost. 2013 Jun;11 Suppl 1:24-35.
116
Lacroix R., Judicone C., Mooberry M., Boucekine M., Key N.S. and Dignat-George F, on behalf of
the ISH SSC Workshop. Standardization of the pre-analytical variables in plasma microparticles
determination: results of the ISTH SSC Collaborative Workshop. J Thromb Haemost. 2013 Apr 2;
11(6): 1190-3.
117
Laine M, Doddo Siddo MN, Paganelli F, Dignat-George F, Bonello L. Improved biological efficacy of
prasugrel one month after an acute coronary syndrome. Int J Cardiol. 2013 Sep 1;167(5):232930.
118
Laine M, Paganelli F, Dignat-George F, Camoin-Jau L, Bonello L. Biological efficacy and clinical
safety of a second 600 mg loading dose of clopidogrel in elderly patients with high on-treatment
platelet reactivity: a pilot study.. Int J Cardiol. 2013 Apr 30;165(1):200-1.
119
Laine M, Toesca R, Berbis J, Frere C, Barnay P, Pansieri M, Peyre JP, Michelet P, Bessereau J,
Camilleri E, Helaf O, Camaleonte M, Paganelli F, Dignat-George F, Bonello L. Platelet reactivity
evaluated with the VASP assay following ticagrelor loading dose in acute coronary syndrome
patients undergoing percutaneous coronary intervention. Thromb Res. 2013 Jul;132(1):e15-8
120
Laine M, Toesca R, Frere C, Paganelli F, Bonello L. Tailoring antiplatelet therapy--insanity orgood
sense? Circ J. 2013;77(5):1150-1. Epub 2013 Mar 23.
12/21
121
Lapidus N, de Lamballerie X, Salez N, Setbon M, Delabre RM, Ferrari P, et al. Factors associated
with post-seasonal serological titer and risk factors for infection with the pandemic A/H1N1 virus
in the French general population. PLoS One 2013;8:e60127.
122
Laquérriere A, Maluenda J, Camus A, Fontenas L, Dieterich K, Nolent F, Zhou J, Monnier N, Latour
P, Gentil D, Héron D, Desguerres I, Landrieu P, Beneteau C, Delaporte B, Bellesme C, Baumann C,
Capri Y, Goldenberg A, Lyonnet S, Bonneau D, Estournet B, Quijano-Roy S, Francannet C, Odent
S, Saint-Frison MH, Sigaudy S, Figarella-Branger D, Gelot A, Mussini JM, Lacroix C, DrouinGarraud V, Malinge MC, Attié-Bitach T, Bessieres B, Bonniere M, Encha-Razavi F, Beaufrère AM,
Khung-Savatovsky S, Perez MJ, Vasiljevic A, Mercier S, Roume J, Trestard L, Saugier-Veber P,
Cordier MP, Layet V, Legendre M, Vigouroux-Castera A, Lunardi J, Bayes M, Jouk PS, Rigonnot L,
Granier M, Sternberg D, Warszawski J, Gut I, Gonzales M, Tawk M, Melki .Mutations in CNTNAP1
and ADCY6 are responsible for severe arthrogryposis multiplex congenita with axoglial defects.
J.Hum Mol Genet. 2013 Dec 20. Le moniteur d'internat 2013
123
Lecompte JF, Hery G, Potier A, Gorincour G, Giudicelli B, Philip N, Guys JM, de Lagausie P.
Putative Criteria for Predicting Spontaneous Regression of Prenatally Diagnosed Thoracoabdominal
Cystic Lesions. Eur J Pediatr Surg. 2013 Sep 5. [Epub ahead of print] PubMed PMID: 24008545.
124
Lee SD, Calfee MW, Mickelsen L, Wolfe S, Griffin J, Clayton M, Griffin-Gatchalian N, Touati A.
Evaluation of surface sampling for Bacillus spores using commercially available cleaning robots.
Environ Sci Technol. 2013 Mar 19;47(6):2595-601.
125
Loyens M, Thuny F, Grisoli D, Fournier PE, Casalta JP, Vitte J, et al. Link between endocarditis on
porcine bioprosthetic valves and allergy to pork. Int J Cardiol 2013;167:600-2.
126
Magalon J, Billard-Daufresne LM, Gilbertas C, Hermanche E, Simon S, Lemarie C, Calmels B,
Sabatier F, Gamerre M, Picard C, Chabannon C. Assessing the HLA diversity of cord blood units
collected from a birth clinic caring for pregnant women in an ethnically diverse metropolitan area.
Transfusion. 2013 Aug 14
127
Marcellin F, Lions C, Winnock M, Salmon D, Durant J, Spire B, Mora M, Loko MA, Dabis F,
Dominguez S, Roux P, Carrieri MP; ANRS CO13 HEPAVIH Study Group. Self-reported alcohol
abuse in HIV-HCV co-infected patients: a better predictor of HIV virological rebound than
physician's perceptions (HEPAVIH ARNS CO13 cohort). Addiction. 2013 Jul;108(7):1250-8.
128
Massicot F., Hache G., David L., Chen D., Leuxe C., Garnier-Legrand L., Laprévote O., Coudoré F.
P2x7 receptor activation and mitochondrial impairment in oxaliplatin-induced neuronal injury.
Beneficial effects of anti-inflammatory or anti-oxidative drugs. PlosOne, 2013 June 27;8.
129
Matta J, Baratin M, Chiche L, Forel JM, Cognet C, Thomas G, et al. Induction of B7-H6, a ligand for
the natural killer cell-activating receptor NKp30, in inflammatory conditions. Blood 2013;122:394404.
130
Maupetit-Méhouas S, Azzi S, Steunou V, Sakakini N, Silve C, Reynes C, Perezde Nanclares G,
Keren B, Chantot S, Barlier A, Linglart A, Netchine I. Simultaneous hyper- and hypomethylation at
imprinted loci in a subset of patientswith GNAS epimutations underlies a complex and different
mechanism of multilocus methylation defect in pseudohypoparathyroidism type 1b. Hum Mutat.
2013Aug;34(8):1172-80. doi: 10.1002/humu.22352. Epub 2013 May 28. PubMed PMID:
23649963.
131
Melenotte C, Rossi P, Reynaud Gaubert M, Harlé JR, Aissi K, Frances Y, et al. Une dyspnée et des
phalanges raccourcies. Rev Med Interne 2013;34:785-6.
132
Michel J, Taïeb D, Jolibert M, Torrents J, Wassef M, Morange I, Essamet W, Barlier A, Dessi P,
Fakhry N. Sinonasal paraganglioma with long-delayedrecurrence and metastases: genetic and
imaging findings. J Clin Endocrinol Metab. 2013 Nov;98(11):4262-6. doi: 10.1210/jc.2013-2320.
Epub 2013 Sep 12. PubMed PMID: 24030938.
13/21
133
Michot C, Corsini C, Sanlaville D, Baumann C, Toutain A, Philip N, Busa T, Holder M, Faivre L,
Odent S, Delrue MA, Till M, Jacquemont ML, Cordier MP, Goldenberg A, Sanchez E, Alix E, Poisson
S, Kayirangwa H, Lacombe D,Gilbert-Dussardier B, Pelet A, Roume J, Jacquette A, Isidor B,
Giuliano F, Burglen L, Fradin M, Schaefer E, Alembick Y, Doray B, Moncla A, Héron D, Willems M,
Pinson L, Le Quan Sang KH, Le Merrer M, Cormier-Daire V, Sarda P, Amiel J, Lyonnet S,
Geneviève D. Finger creases lend a hand in Kabuki syndrome. Eur J Med Genet. 2013
Oct;56(10):556-60. doi: 10.1016/j.ejmg.2013.07.005. Epub 2013 Aug 7. PubMed PMID:
23933090.
134
Milano G, Fanciullino R, Ciccolini J. Research highlights. Pharmacogenomics 07/2013; 14(9):10079.
135
Million M, Walter G, Bardin N, Camoin L, Giorgi R, Bongrand P, et al. Immunoglobulin G
anticardiolipin antibodies and progression to Q fever endocarditis. Clin Infect Dis 2013;57:57-64.
136
Mionnet C, Mondor I, Jorquera A, Loosveld M, Maurizio J, Arcangeli ML, Ruddle NH, Nowak J,
Aurrand-Lions M, Luche H, Bajénoff M. Identification of a new stromal cell type involved in the
regulation of inflamed B cell follicles. PLoS Biol. 2013 ;11:e1001672.
137
Morange PE, Alessi MC.Thrombosis in central obesity and metabolic syndrome: Mechanisms and
epidemiology. J Thromb Haemost. 2013;110-3 (IF = 6.081)
138
Morange PE, Trégouët DA.Current knowledge on the genetics of incident venous thrombosis.
139
Moro PJ, Quilici J, Giorgi R, Cuisset T, By Y, Boussuges A, Jammes Y, Bonnet JL, Ruf J, Fenouillet
E, Guieu R. Mononuclear cell adenosine deaminase and CD26/dipeptidylpeptidase-IV activities are
sensitive markers of reperfusion during percutaneous transluminal angioplasty. Int J Cardiol. 2013
Jun 5;166(1):225-9.
140
Narni-Mancinelli E, Ugolini S, Vivier E. Les cellules natural killer - Adaptation et mémoire dans le
système immunitaire inné Med Sci (Paris) 2013;29:389-95.
141
Narni-Mancinelli E, Ugolini S, Vivier E. Tuning the threshold of natural killer cell responses. Curr
Opin Immunol 2013;25:53-8.
142
Navarro C., De Sandre-Giovannoli A., Cantecor B., Roll P., Lévy N., Cau P. Ten years of
translational research and valorisation in Progeria, from genetics to therapeutic applications and
cosmetic. Médecine Sciences Amérique 2013;2(3):79-93.
143
Navarro CL., Esteves-Vieira V., Courrier S., Boyer A., Nguyen TD., Huong LTT., Meinke P.,
Schröder W., Cormier-Daire V., Sznajer Y., Amor D., Lagerstedt K., Biervliet M., van den Akker P.,
Cau P., Roll P., Lévy N., Badens C., Wehnert M., De Sandre-Giovannoli A. ZMPSTE24 (FACE1)
mutations in patients affected with Restrictive Dermopathy and related progeroid syndromes.
European Journal of Human Genetics 2013 Epub Oct 30.
144
Nee L, Franceschi F, Resseguier N, Gravier G, Giorgi R, Gariboldi V, Collart F, Michelet P, Deharo
JC, Guieu R, Kerbaul F. High endogenous adenosine plasma concentration is associated with atrial
fibrillation during cardiac surgery with cardiopulmonary bypass. Int J Cardiol. 2013 Apr
30;165(1):201-4. doi: 10.1016/j.ijcard.2012.08.018. Epub 2012 Sep 29. PubMed PMID:
23026311.
145
Nee L, Giorgi R, Garibaldi V, Bruzzese L, Blayac D, Fromonot J, Kipson N, Bellezza M, Lejeune PJ,
Guieu R, Kerbaul F. Ischemia-modified albumin and adenosine plasma concentrations are
associated with severe systemic inflammatory response syndrome after cardiopulmonary bypass.
J Crit Care. 2013 Oct;28(5):747-55. doi: 10.1016/j.jcrc.2013.02.014.
14/21
146
Nogueira JP, Maraninchi M, Lorec AM, Samuelian-Massat C, Begu-Le Corroller A, Nicolay A,
Gaudart J, Portugal H, Vialettes B, Valéro R.Growth hormone level at admission and its evolution
during refeeding is predictive of short term outcome in restrictive anorexia nervosa. Brit J Nutr,
2013, 109(12): 2175-81.
147
Nogueira JP, Valéro R, Maraninchi M, Lorec AM, Samuelian-Massat C, Bégu-Le Corroller A, Nicolay
A, Gaudart J, Portugal H, Vialettes B. Growth hormone level at admission and its evolution during
refeeding is predictive of short term outcome in restrictive anorexia nervosa. Brit J
Nutr.2013;109:2175-8 (IF = 3.342
148
Noris P, Favier R, Alessi MC, Geddis AE, Kunishima S, Heller PG, Giordano P, Niederhoffer KY,
Bussel JB, Podda GM, Vianelli N, Kersseboom R, Pecci A, Gnan C, Marconi C, Auvrignon A, Cohen
W, Yu JC, Iguchi A, Miller Imahiyerobo A, Boehlen F, Ghalloussi D, De Rocco D, Magini P, Civaschi
E, Biino G, Seri M, Savoia A, Balduini CL. ANKRD26-related thrombocytopenia and myeloid
malignancies. Blood. 2013;122:1987-9. (IF = 9.060)
149
Oulidi A, Bokhobza A, Gkika D, Vanden Abeele F, Lehen'kyi V, Ouafik L, Mauroy B, Prevarskaya N.
TRPV2 mediates adrenomedullin stimulation of prostate and urothelial cancer cell adhesion,
migration and invasion. PLoS One. 2013;8(5):e64885.
150
Pankert M, Quilici J, Loundou AD, Verdier V, Lambert M, Deharo P, Bonnet G, Gaborit B, Morange
PE, Valéro R, Dutour A, Bonnet JL, Alessi MC, Cuisset T. Impact of obesity and the metabolic
syndrome on response to clopidogrel or prasugrel and bleeding risk in patients treated after
coronary stenting. Am J Cardiol. 2014;113(1):54-9. (IF = 3.425)
151
Pankert M, Quilici J, Loundou AD, Verdier V, Lambert M, Deharo P, Bonnet G, Gaborit B, Morange
PE, Valéro R, Dutour A, Bonnet JL, Alessi MC, Cuisset T. Impact of obesity and the metabolic
syndrome on response to clopidogrel or prasugrel and bleeding risk in patients treated after
coronary stenting. Am J Cardiol. 2014; 1;113:54-9. (IF = 3.425)
152
Pellegrini L, Bennis Y, Guillet B, Velly L, Bruder N, Pisano P. Cell therapy for stroke: from myth to
reality. Rev Neurol (Paris). 2013 Apr ; 169(4):291-306
153
Pellegrini L., Bennis Y., Guillet B., Velly L, Sabatier F, Dignat-George F, Nicolas Bruder, Pisano.P.
Therapeutic benefit of a combined strategy using erythropoietin and endothelial progenitor cells
after transient focal cerebral ischaemia in rats. Neurol Res 2013 Nov,35(9):937-47
154
Pereyre S, Touati A, Petitjean-Lecherbonnier J, Charron A, Vabret A, Bébéar C. The increased
incidence of Mycoplasma pneumoniae in France in 2011 was polyclonal, mainly involving M.
pneumoniae type 1 strains. Clin Microbiol Infect. 2013 Apr;19(4):E212-7.
155
Perez-Martinez P, Garcia-Rios A, Delgado-Lista J, Gjelstad IM, Gibney J, Kieć-Wilk B, Camargo A,
Helal O, Karlström B, Blaak EE, Hall W, Risérus U, Dembińska-Kieć A, Defoort C, Saris WH,
Lovegrove JA, Drevon CA, Roche HM, Lopez-Miranda J. Gene-nutrient interactions on the
phosphoenolpyruvatecarboxykinase influence insulin sensitivity in metabolic syndrome subjects.
Clin Nutr. 2013;32:630-5 (IF = 3.731)
156
Perrin S, Cremer J, Faucher O, Reynes J, Dellamonica P, Micallef J, Solas C, Lacarelle B, Stretti C,
Kaspi E, Robaglia-Schlupp A, Tamalet CN, Lévy N, Poizot-Martin I, Cau P, Roll P. Correction: HIV
Protease Inhibitors Do Not Cause the Accumulation of Prelamin A in PBMCs from Patients
Receiving First Line Therapy: The ANRS EP45 "Aging" Study. PLoS One. 2013 Aug 14;8(8).
157
Perron H, Germi R, Bernard C, Garcia-Montojo M, Deluen C, Farinelli L, et al. Re: Errors in the
editorial by Christensen and Giovannoni [HERVs: have we been here before? MSJ 18(12) 16701672]. Mult Scler 2013;19:831-2.
158
Peters GJ, Honeywell RJ, Maulandi M, Giovannetti E, Losekoot N, Etienne-Grimaldi MC, Milano G,
Serdjebi C, Ciccolini J; EORTC-Pharmacology and Molecular Mechanism Group. Selection of the
best blood compartment to measure cytidine deaminase activity to stratify for optimal
gemcitabine or cytarabine treatment. Nucleosides Nucleotides Nucleic Acids. 2014;33(4-6):40312.
15/21
159
Phillips CM, Tierney AC, Perez-Martinez P, Defoort C, Blaak EE, Gjelstad IM, Lopez-Miranda J, KiecKlimczak M, Malczewska-Malec M, Drevon CA, Hall W, Lovegrove JA, Karlstrom B, Risérus U, Roche
HM. Obesity and Body Fat Classification in the Metabolic Syndrome: Impact on Cardiometabolic
Risk Metabotype.Obesity. 2013;1:e154-61 (IF = 4.389)
160
Phillips CM, Tierney AC, Perez-Martinez P, Defoort C, Blaak EE, Gjelstad IM, Lopez-Miranda J, KiecKlimczak M, Malczewska-Malec M, Drevon CA, Hall W, Lovegrove JA, Karlstrom B, Risérus U, Roche
HM. Obesity and body fat classification in the metabolic syndrome: impact on cardiometabolic risk
metabotype. Obesity (Silver Spring). 2013;21: E154-61 (IF = 4.389)
161
Plaisancié J, Bailleul-Forestier I, Gaston V, Vaysse F, Lacombe D, Holder-Espinasse M, Abramowicz
M, Coubes C, Plessis G, Faivre L, Demeer B, Vincent-Delorme C, Dollfus H, Sigaudy S, GuillénNavarro E, Verloes A, Jonveaux P, Martin-Coignard D, Colin E, Bieth E, Calvas P, Chassaing.
Mutations in WNT10A are frequently involved in oligodontia associated with minor signs of
ectodermal dysplasia. N.Am J Med Genet A. 2013 Apr;161A(4):671-8.
162
Plantier S, Harlé JR, Gautier M, Bertin D, Granel B, Sarles J, et al. Dépistage et suivi
immunologique de la maladie c?liaque : expérience du CHU de Marseille. Rev Med Interne
2013;34:735-40.
163
Poggi M, Kara I, Brunel JM, Landrier JF, Govers R, Bonardo B, Fluhrer R, Haass C, Alessi MC,
Peiretti F. Palmitoylation of TNF alpha is involved in the regulation of TNF receptor 1 signaling.
Biochimica et Biophisica Acta Mol Cell Res. 2013;1833:602-12 (IF = 5.538)
164
Poizot-Martin I, Faucher O, Obry-Roguet V, Nicolino-Brunet C, Ronot-Brégigeon S, Dignat-George
F, Tamalet C. Lack of correlation between the size of HIV proviral DNA reservoir and the level of
immune activation in HIV-infected patients with a sustained undetectable HIV viral load for 10
years. J Clin Virol. 2013 Aug;57(1):351-5
165
Poizot-Martin I, Solas C, Allemand J, Obry-Roguet V, Pradel V, Bregigeon S, Faucher O, Lacarelle
B. Renal impairment in patients receiving a tenofovir-cART regimen: impact of tenofovir trough
concentration. J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):375-80.
Poli A, Kmiecik J, Domingues O, Hentges F, Bléry M, Chekenya M, et al. NK cells in central
nervous system disorders. J Immunol 2013;190:5355-62.
166
167
Popovici C, Busa T, Missirian C, Milh M, Moncla A, Philip N. Mosaic 15q13.3 deletion including
CHRNA7 gene in monozygotic twins. Eur J Med Genet. 2013 May;56(5):274-7. doi:
10.1016/j.ejmg.2013.02.005. Epub 2013 Feb 27. PubMed PMID: 23454271.
168
Pradeu T, Jaeger S, Vivier E. The speed of change: towards a discontinuity theory of immunity?
Nat Rev Immunol 2013;13:764-9.
169
Prugger C, Luc G, Haas B, Morange PE, Ferrieres J, Amouyel P, Kee F, Ducimetiere P, Empana JP;
PRIME Study Group. Multiple biomarkers for the prediction of ischemic stroke: the PRIME
study.ArteriosclerThromb Vasc Biol. 2013;33:659-66 (IF = 6.338)
170
Quilici J, Fugon L, Beguin S, Morange PE, Bonnet JL, Alessi MC, Carrieri P, Cuisset T. Effect of
motivational mobile phone short message service on aspirin adherence after coronary stenting for
acute coronary syndrome. Int J Cardiol. 2013;168(1):568-9 (IF = 6.802)
171
Quilici J, Fugon L, Beguin S, Morange PE, Bonnet JL, Alessi MC, Carrieri P, Cuisset T. Effect of
motivational mobile phone short message service on aspirin adherence after coronary stenting for
acute coronary syndrome. Int J Cardiol. 2013;168:568-9. (IF = 5.509)
172
Regaya I, Aidi-Knani S, By Y, Condo J, Gerolami V, Berge-Lefranc JL, Ben Hamida J, Sabatier JM,
Fenouillet E, Guieu R, Ruf J. SKCa Channels Blockage Increases the Expression of Adenosine A2A
Receptor in Jurkat Human T Cells. Biores Open Access. 2013 Apr;2(2):163-8.
173
Regaya I, Aidi-Knani S, By Y, Condo J, Gerolami V, Berge-Lefranc JL, BenHamida J, Sabatier JM,
Fenouillet E, Guieu R, Ruf J. SKCa Channels Blockage Increases the Expression of Adenosine A2A
Receptor in Jurkat Human T Cells. Biores Open Access. 2013 Apr;2(2):163-8. doi:
10.1089/biores.2012.0282. PubMedPMID: 23593569; PubMed Central PMCID: PMC3620471.
16/21
174
Robert P, Touchard D, Bongrand P, Pierres A. Biophysical description of multiple events
contributing blood leukocyte arrest on endothelium. Front Immunol 2013;4:108.
175
Rodien P, Barlier A. [French Society of Endocrinology, Paris 2013]. AnnEndocrinol (Paris). 2013
Sep;74(4):235. doi: 10.1016/j.ando.2013.07.002. Epub2013 Aug 20. French. PubMed PMID:
23972380.
176
Rusakiewicz S, Nocturne G, Lazure T, Semeraro M, Flament C, Caillat-Zucman S, et al.
NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome. Sci Transl Med
2013;5:195ra96.
177
Sabater-Lleal M, Huang J, Chasman DI, Naitza S, Dehghan A, Johnson AD, Teumer A, Reiner AP,
Folkersen L, Basu S, Rudnicka AR, Trompet S, Mälarstig A, Baumert J, Bis JC, Guo X, Hottenga JJ,
Shin SY, Lopez LM, Lahti J, Tanaka T, Yanek LR, Oudot-Mellakh T, Wilson JF, Navarro P, Huffman
JE, Zemunik T, Redline S, Mehra R, Pulanic D, Rudan I, Wright AF, Kolcic I, Polasek O, Wild SH,
Campbell H, Curb JD, Wallace R, Liu S, Eaton CB, Becker DM, Becker LC, Bandinelli S, Räikkönen
K, Widen E, Palotie A, Fornage M, Green D, Gross M, Davies G, Harris SE, Liewald DC, Starr JM,
Williams FM, Grant PJ, Spector TD, Strawbridge RJ, Silveira A, Sennblad B, Rivadeneira F,
Uitterlinden AG, Franco OH, Hofman A, van Dongen J, Willemsen G, Boomsma DI, Yao J, Jenny
NS, Haritunians T, McKnight B, Lumley T, Taylor KD, Rotter JI, Psaty BM, Peters A, Gieger C, Illig
T, Grotevendt A, Homuth G, Völzke H, Kocher T, Goel A, Franzosi MG, Seedorf U, Clarke R, Steri
M, Tarasov KV, Sanna S, Schlessinger D, Stott DJ, Sattar N, Buckley BM, Rumley A, Lowe GD,
McArdle WL, Chen MH, Tofler GH, Song J, Boerwinkle E, Folsom AR, Rose LM, Franco-Cereceda A,
Teichert M, Ikram MA, Mosley TH, Bevan S, Dichgans M, Rothwell PM, Sudlow CL, Hopewell JC,
Chambers JC, Saleheen D, Kooner JS, Danesh J, Nelson CP, Erdmann J, Reilly MP, Kathiresan S,
Schunkert H, Morange PE, Ferrucci L, Eriksson JG, Jacobs D, Deary IJ, Soranzo N, Witteman JC,
de Geus EJ, Tracy RP, Hayward C, Koenig W, Cucca F, Jukema JW, Eriksson P, Seshadri S, Markus
HS, Watkins H, Samani NJ, Wallaschofski H, Smith NL, Trégouët D, Ridker P, Tang W, Strachan
DP, Hamsten A, O'Donnell CJ. Multi-Ethnic Meta-Analysis of Genome-Wide Association Studies in
Over 100,000 Subjects Identifies 23 Fibrinogen-Associated Loci but no Strong Evidence of a
Causal Association between Circulating Fibrinogen and Cardiovascular Disease. Circulation. 2013
17;128:1310-24. (IF = 15.202)
178
Sallee M, Fontes M, Louis L, Cerini C, Brunet P, Burtey S. Alternative Splicing Events Is Not a Key
Event for Gene Expression Regulation in Uremia. PLoS One. 2013 Dec 16;8(12):e82702
179
Sallée M, Fontès M, Louis L, Cérini C, Brunet P, Burtey S. Alternative splicing events is not a key
event for gene expression regulation in uremia. PLoS One. 2013;8:e82702. (IF = 3.730)
180
Salort-Campana E1, Nguyen K, Lévy N, Pouget J, Attarian S.Clinical and molecular diagnosis of
facioscapulohumeral dystrophy type 1 (FSHD1) in 2012.Rev Neurol (Paris). 2013 Aug-Sep;169(89):573-82.
181
Sanchez R, Picard N, Mouly-Bandini A, Chalvignac V, Lacarelle B, Sampol-Manos E. Severe
decrease of cyclosporine levels in a heart transplant recipient receiving the direct thrombin
inhibitor argatroban. Ther Drug Monit. 2014 Jun;36(3):273-7.
182
Sarlon-Bartoli G., Bennis Y., Lacroix R., Piercecchi-Marti MD., Bartoli MA., Arnaud L., Boudes
A., Sarlon E., Thevenin B., Leroyer AS., Squarcioni C., Magnan PE., Dignat-George F. and Sabatier
F. Plasmatic levels of leukocyte-derived microparticles predict unstable plaque in asymptomatic
patients with high-grade carotid stenosis. J Am Coll Cardiol. 2013 Oct 15;62(16):1436-41.
183
Saveanu A, Sebag F, Guillet B, Archange C, Essamet W, Barlier A, Palazzo FF, Taïeb D. Targeting
Dopamine Receptors Subtype 2 (D2DR) in Pheochromocytomas: Head-to-Head Comparison
Between In Vitro and In Vivo Findings. J Clin Endocrinol Metab. 2013 Dec;98(12):E1951-5. doi:
10.1210/jc.2013-2269. Epub 2013 Sep 5. PubMed PMID: 24009136.
184
Scodavolpe S, Quaranta S, Lacarelle B, Solas C. Triazole antifungal agents: practice guidelines of
therapeutic drug monitoring and perspectives in treatment optimization. Ann Biol Clin (Paris).
2014 Aug 1;72(4):391-404
17/21
185
Serdjebi C, Ciccolini J, Fina F, Delarue A, Verschuur A, Lacarelle B, Ouafik L, André N.
Recipient/donor contradictory genotypes with impact on drug pharmacogenetics after liver
transplant: A deadly gift? Pharmacogenet Genomics. 2014 Jul 7. [Epub ahead of print]
186
Serdjebi C, Seitz JF, Ciccolini J, Duluc M, Norguet E, Fina F, Lacarelle B, Ouafik L, Dahan L. Rapid
deaminator status is associated with poor clinical outcome in pancreatic cancer patients treated
with a gemcitabine-based regimen. Pharmacogenomics. 2013 Jul;14(9):1047-51. doi:
10.2217/pgs.13.93.
187
Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. Innate lymphoid cells--a
proposal for uniform nomenclature. Nat Rev Immunol 2013;13:145-9.
188
Stalin J, Harhouri K, Hubert L, Subrini C, Lafitte D, Lissitzky JC, et al. Soluble melanoma cell
adhesion molecule (sMCAM/sCD146) promotes angiogenic effects on endothelial progenitor cells
through angiomotin. J Biol Chem 2013;288:8991-9000.
189
Stepanian A, Bourguignat L, Henou S, Coupaye M, Samomon L, Alessi MC, Msika S, De Prost D.
Microparticle increase in severe obesity: not related to metabolic syndrome and unchanged after
massive weight loss. Obesity. 2013;2236-43 (IF = 4.389)
190
Stephan D, Sbai O, Wen J, Couraud PO, Putterman C, Khrestchatisky M, et al. TWEAK/Fn14
pathway modulates properties of a human microvascular endothelial cell model of blood brain
barrier. J Neuroinflammation 2013;10:9.
191
Taïeb D, Yang C, Delenne B, Zhuang Z, Barlier A, Sebag F, Pacak K. Firstreport of bilateral
pheochromocytoma in the clinical spectrum of HIF2A-relatedpolycythemia-paraganglioma
syndrome. J Clin Endocrinol Metab. 2013May;98(5):E908-13. doi: 10.1210/jc.2013-1217. Epub
2013 Mar 28. PubMed PMID: 23539726; PubMed Central PMCID: PMC3644612.
192
Tang W, Teichert M, Chasman DI, Heit JA, Morange PE, Li G, Pankratz N, Leebeek FW, Paré G, de
Andrade M, Tzourio C, Psaty BM, Basu S, Ruiter R, Rose L, Armasu SM, Lumley T, Heckbert SR,
Uitterlinden AG, Lathrop M, Rice KM, Cushman M, Hofman A, Lambert JC, Glazer NL, Pankow JS,
Witteman JC, Amouyel P, Bis JC, Bovill EG, Kong X, Tracy RP, Boerwinkle E, Rotter JI, Trégouët
DA, Loth DW, Stricker BH, Ridker PM, Folsom AR, Smith NL.A genome-wide association study for
venous thromboembolism: the extended cohorts for heart and aging research in genomic
epidemiology (CHARGE) consortium.Genet Epidemiol. 2013;37:512-21 (IF = 4.015)
193
Textoris J, Ivorra D, Ben Amara A, Sabatier F, Ménard JP, Heckenroth H, Bretelle F, Mege JL.
Evaluation of Current and New Biomarkers in Severe Preeclampsia : A Microarray Approach
Reveals theVSIG4 Gene as a Potential Blood Biomarker. PLoS One. 2013 Dec 9;8(12):e82638
194
Thevenon J, Bourredjem A, Faivre L, Cardot-Bauters C, Calender A, Murat A, Giraud S, Niccoli P,
Odou MF, Borson-Chazot F, Barlier A, Lombard-Bohas C, Clauser E, Tabarin A, Parfait B, Chabre
O, Castermans E, Beckers A, RuszniewskiP, Le Bras M, Delemer B, Bouchard P, Guilhem I,
Rohmer V, Goichot B, Caron P, Baudin E, Chanson P, Groussin L, Du Boullay H, Weryha G,
Lecomte P, Penfornis A, Bihan H, Archambeaud F, Kerlan V, Duron F, Kuhn JM, Vergès B, Rodier
M, Renard M, Sadoul JL, Binquet C, Goudet P. Higher risk of death among MEN1 patients
withmutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE)
cohort study. Hum Mol Genet. 2013 May 15;22(10):1940-8. doi10.1093/hmg/ddt039. Epub 2013
Jan 31. PubMed PMID: 23376981.
195
Tran Mau-Them F, Willems M, Albrecht B, Sanchez E, Puechberty J, Endele S, Schneider A, Ruiz
Pallares N, Missirian C, Rivier F, Girard M, Holder M, Manouvrier S, Touitou I, Lefort G, Sarda P,
Moncla A, Drunat S, Wieczorek D, Genevieve D. Expanding the phenotype of IQSEC2 mutations:
truncating mutations in severe intellectual disability. Eur J Hum Genet. 2013 May 15.
196
Trouillas J, Roy P, Sturm N, Dantony E, Cortet-Rudelli C, Viennet G, Bonneville JF, Assaker R,
Auger C, Brue T, Cornelius A, Dufour H, Jouanneau E, François P, Galland F, Mougel F, Chapuis F,
Villeneuve L, Maurage CA, Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillère R, Hannani D, et
al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide.
Science 2013;342:971-6.
18/21
197
Visentin S, Baudesson de Chanville A, Loosveld M, Chambost H, Barlogis V.[Infantile visceral
leishmaniasis, an etiology of easily curable hemophagocytic lymphohistiocytosis syndrome]. Arch
Pediatr. 2013 ;20:1225-9.
198
Vitte J, Bongrand P. Serum tryptase determination in patients with acute allergic reactions. J
Allergy Clin Immunol 2013;131:1714.
199
Vivier E, Ugolini S, Nunès JA. ADAPted secretion of cytokines in NK cells. Nat Immunol
2013;14:1108-10.
200
Vors C, Pineau G, Gabert L, Drai J, Louche-Pélissier C, Defoort C, Lairon D, Désage M, Danthine S,
Lambert-Porcheron S, Vidal H, Laville M, Michalski MC. Modulating absorption and postprandial
handling of dietary fatty acids by structuring fat in the meal: a randomized crossover clinical trial.
Am J ClinNutr. 2013;97:23-36 (IF = 6.669)
201
Wood JP, Calfee MW, Clayton M, Griffin-Gatchalian N, Touati A, Egler K. Evaluation of peracetic
acid fog for the inactivation of Bacillus anthracis spore surrogates in a large decontamination
chamber. J Hazard Mater. 2013 Apr 15;250-251:61-7.
CONTRATS ANNÉE 2013
S. ATTARIAN – « Outils pour l’évaluation thérapeutique dans la maladie de Charcot-Marie-Tooth de type
IA : critères de jugement et biomarqueurs » - AP-HM – PHRC Inter régional 2013
P. ROLL : « Matrice nucléaire et Cancers : analyses génomique par puces à ADN et protéique des cellules
obtenues par ponction pleurale », ARARD (2009-2013)
P. ROLL : « Microparticules, vecteurs d’information génétique au cours de l’infection par le VIH ? », Projet
de recherche ANRS (2012-2013)
L. NEE : Effets de la caféine dans le FA post opératoire – AORCA. HAUTIER « RECHERCHE DE BIOMARQUEURS INNOVANTS : EXPRESSION DE HIF-1α ET DE SES
ISOFORMES DANS LE SANG ET LES TISSUS CUTANES DES GRANDS BRULES » - AORC Investigateurs associés : Amin BEN LASSOUED et Pr Jean GABERT. Références CPP : 2012-23 /
Référence du Comité : 12 49 / Numéro d'identification : 2012-A00644
A. BARLIER/ A. SAVEANU/ A. ENJALBERT : Nouveaux déterminants moléculaires des déficits
hypophysaires - ANR 2008-2013
V. GEROLAMI : Essai thérapeutique TICAGRELOR 2012-2013
V. GEROLAMI : Hémochromatose de type 4 - Ministère santé PHRC -2010-2013
A. BARLIER . H. ZATTARA : Séquencage du gène VHL dans les hémangioblastomes, impact
psychologique lors de la reconvocation des patients - AORC 2013 - 2013-2014
N. LEVY: Neuromics - CEE FP7-305121 -Nov 2012
N. LEVY: MNH-DECRYPT : Genomics, pathophysiology and therapeutic approaches in a panel of rare
genetics diseases mainly affecting muscle, heart and nervous system – AFM- Juin 2010
19/21
J. CICCOLINI - « Pharmacocinétique du bévacizumab » Subvention Cancéropôle 2013
J. CICCOLINI - Recherche des effets séquernces anti-angiogéniques/cytotoxiques » Contrat Roche 2013
J. CICCOLINI - « Développement des ANC »Subvention Gefluc 2013
C. DUBOIS -« Rôles des microparticules dans l’initiation et la régulation des processus de thromboses et
de métastases » MiniRev – ANR -2009 2013
C. DUBOIS -« Rôle des plaquettes sanguines dans le développement d’une tumeur et la formation de
métastases dans un modèle murin du cancer du pancréas » - ARC-2012 2013
U. SIMEONI F. SABATIER - « Encéphalopathie anoxo-ischémique néonatale : étude de la tolérance et de
la faisabilité d’un traitement curatif par les cellules souches du sang du cordon ombilical »- PHRC- 2010
2013
B.GRANEL N. BARDIN - « Sclérodermie et marqueurs vasculaires » - AORC Sénior- 2013
J.R. HARLE F. DIGNAT-GEORGE - « Etude de la lésion endothéliale dans la Drépanocytose »- AORC Sénior
– 2011 2013
P. PAUL - « Evaluation de la réaction humorale et cellulaire anti-endothéliale dans la survenue du rejet de
greffe cardiaque » - AAP 2010 Recherche Clinique Translationnelle -2010 2013
F. DIGNAT-GEORGE - « CD 146 nouvelle cible dans les pathologies vasculaires » -FONDATION DE
FRANCE – 2012 2014
C.DUBOIS - « Etude du pouvoir antitumoral du Clopidrogrel dans un modèle murin du cancer du
pancréas » - FORMATION RECHERCHE TRANSLATIONNELLE EN CANCEROLOGIE-2009 2013
C.DUBOIS - « Study of the antitumoral effect of Clopidogrel in a mouse model of pancreatic cancer » GFTC – 2012 2013
F. DIGNAT-GEORGE - Exploratory assessment of biomarkers in female patients suffering from chronic
venous leg ulcer versus control subjects free of leg ulcer - Laboratoire SERVIER- 2013
M.CANAULT /M.C.ALESSI - Bases cellulaires et moléculaires du risque thrombotique dans l'insulino
résistance : étude dans la plaquette - Fondation de France – 2012 2013
M.C. ALESSI - Rôle de la molécule de costimulation CD28 dans le développement de l'état inflammatoire
et de la résistance à l'insuline associés à l'obésité - Société Fancophone de Diabète- 2012 2013
M.C. ALESSI - Subvention Annuelle – FRM- 2013
BREVETS ANNÉE 2013
Method for assessing the ability of a patient to respond to or be safely treated by a nucleoside analog
based-chemotherapy. Inventeurs : Ciccolini, Mercier, Dahan, Iliadis, Seitz, Ouafik. N° dépôt : US
20130011392 A1. Année de dépôt :2009. Année de publication : 10 janvier 2013. Déposant AMU, codéposant : AP-HM.
Method for assessing the ability of a patient to respond to or be safely treated by a nucleoside analog
based-chemotherapy Brevet - États-Unis US 20130011392 A1 Publié le 10 janvier 2013
Développement d’un système de lecture automatisé. Bertin D, Bongrand P, Bardin N. European patent n°
1000191432. 2013. AP-HM.
20/21
THESES DE DOCTORAT ANNÉE 2013
Mathey-Turba Camille –« « JAK2 et syndromes myeloproliferatifs : comparaison de méthodes
diagnostiques » - 18 janvier 2013.
Franceschi Frédéric « Contribution à l’étude du système adénosinergique en pathologie cardiovasculaire »
- 22 Février 2013
Bennis Youssef . L'érythropoïétine, agent d'optimisation de la thérapie cellulaire par progéniteurs
endothéliaux dans l'AVC ischémique et l'ischémie aigüe des membres inférieurs. Mars 2013
Taulelle Jean-Marie – « Quantification de la mutation JAK2 V617 F : Que faire des patients faiblement
positifs ? Etude de 165 patients JAK2 V617F positifs entre 2008 et 2010 à l’AP-HM » - 21 juin 2013.
Bonello Nathalie. Conséquences des laminopathies dans l’endothélium vasculaire. Septembre 2013
Favier Marie. Pathologies plaquettaires héréditaires : caractérisation d’une nouvelle mutation. Septembre
2013
Gravier Gilles « Cinétique des réponses cardiorespiratoires et métaboliques lors d’un exercice
incrémentiel maximal chez l’homme » – 18 novembre 2013.
Gondouin Bertrand. Les toxines urémiques provoquent un phénotype procoagulant de l’endothélium par
la voie du facteur de transcription AHR. Novembre 2013
Darbousset Roxane. Rôle des polynucléaires neutrophiles dans la formation d'un thrombus in vivo dans un
modèle murin après blessure au rayon laser. Décembre 2013
Amira Mohamed. Nouvelles molécules thérapeutiques en développement pour les Tumeurs
Neuroendocrines d’origine gastroentéropancréatiques et hypophysaires: Preuves de concept in vitro dec
2013
21/21

unite de recherche - Faculté de Médecine

Transcription

Documents pareils

01 - Longs Crins

un petit calendrier vous est proposé en téléchargement

5733015 1. Record Nr. Titolo Invertébrés d`eau douce

Bachelor

Calendrier de récupération plastique agricole

Gîte 5 - L`île Berder 2012 Janvier (01) Février (02) Mars (03) Avril

(synthèse - modif actes du colloque)